Search clinical trials for: imiquimod cream

Total 1473 results

Graceway Pharmaceuticals, LLC

Completed

Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts

Genital Warts

United States
Graceway Pharmaceuticals, LLC

Completed

Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts

Genital Warts

United States
Graceway Pharmaceuticals, LLC

Completed

Cellular and Molecular Events During Treatment of Actinic Keratosis With Imiquimod 5% Cream

Actinic Keratosis

United States
Taro Pharmaceuticals USA

Completed

Clinical Study to Evaluate the Bioequivalence of Two Imiquimod Cream 3.75% Formulations in Patients With Actinic Keratosis.

Actinic Keratosis
Graceway Pharmaceuticals, LLC

Completed

Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis

Keratosis

United States
Graceway Pharmaceuticals, LLC

Completed

Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream

Superficial Basal Cell Carcinoma

Australia, New Zealand
Graceway Pharmaceuticals, LLC

Completed

Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)

Actinic Keratosis

United States
Graceway Pharmaceuticals, LLC

Completed

Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery

Actinic Keratosis

United States, Canada
Teva Pharmaceuticals USA

Completed

Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis

Actinic Keratosis

United States
Medicis Global Service Corporation

Unknown

Potential Effect of Topical Imiquimod on Atrial Ectopy in Patients With Actinic Keratosis

Actinic Keratosis

United States
Actavis Mid-Atlantic LLC

Completed

A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses

Actinic Keratoses

United States
Apotex Inc.

Completed

A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled Therapeutic Equivalence Study of Three Imiquimod Cream 5% Treatments for Patients With Actinic Keratosis

Actinic Keratosis
Medical University Innsbruck

Not yet recruiting

Adjuvant Anal Imiquimod Therapy in Anal HPV-lesions: AdAM-trial (AdAM)

Anogenital Human Papillomavirus Infection | Condyloma Anal

Austria
VA Office of Research and Development

Not yet recruiting

Basal Cell Carcinoma Chemoprevention Trial (B3C)

Basal Cell Carcinoma

United States
The Royal Bournemouth Hospital
CLL Topics, Inc.

Terminated

Study of Immune Responses to Influenza Vaccination With or Without Imiquimod Application in Untreated CLL Patients (CLLIFVAC)

Chronic Lymphocytic Leukemia

United Kingdom
University of Utah

Completed

Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna

Cancer | Lentigo Maligna

United States
Medical University of Vienna

Terminated

Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant Recipients (AKtransplant)

Actinic Keratoses

Austria
St. Justine's Hospital
Graceway Pharmaceuticals, LLC

Completed

A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy

Hemangioma, Capillary

Canada
Icahn School of Medicine at Mount Sinai
Bausch Health Americas, Inc.

Completed

Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream

Actinic Keratosis

United States
MEDA Pharma GmbH & Co. KG
ORION Sante

Completed

Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients

Warts

Belgium, France
Massachusetts General Hospital

Completed

Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1

Neurofibromatosis Type 1 | Cutaneous Neurofibromas

United States
The Hospital for Sick Children

Completed

Imiquimod in Children With Plaque Morphea

Scleroderma, Localized

Canada
Graceway Pharmaceuticals, LLC

Completed

Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)

Actinic Keratoses

United States
Graceway Pharmaceuticals, LLC

Completed

1-Year Follow up to the 1473-IMIQ Study

Keratosis

United States
MEDA Pharma GmbH & Co. KG

Completed

A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients

Actinic Keratosis
The University of Hong Kong

Not yet recruiting

Influenza Vaccine With Topical Imiquimod in Influenza Vaccine Non-responsive Children

Influenza
Graceway Pharmaceuticals, LLC

Completed

A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence

Basal Cell Carcinoma

United States
MEDA Pharma GmbH & Co. KG

Completed

Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions

Actinic Keratosis

France
University of Alberta
3M

Withdrawn

Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study

Morphea

Canada
The University of Hong Kong

Completed

HBV Vaccine in Renal Failure Patients

Renal Failure

Hong Kong
Medical University of Graz

Completed

Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream

Actinic Keratoses

Austria
University of Pennsylvania

Terminated

Imiquimod for Preventing Keloid Recurrence

Keloid

United States
Graceway Pharmaceuticals, LLC

Completed

Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands

Keratosis

United States
The University of Hong Kong

Completed

Intradermal Influenza Vaccine in the Young

Influenza Viral Infections

China
Nantes University Hospital
MEDA Pharma GmbH & Co. KG

Completed

Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face (ImiReduc)

Lentigo Maligna Melanoma (Head or Neck)

France
Actavis Inc.

Completed

Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis

Actinic Keratoses

United States
Rigel Dermatology

Completed

Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses

Actinic Keratoses

United States
University of Sao Paulo

Unknown

Imiquimod 5% Cream for the Treatment of Periocular Basal Cell Carcinoma (Imiquimod)

Carcinoma, Basal Cell

Brazil
University of Glasgow
NHS Greater Glasgow and Clyde; Glasgow Western Infirmary

Unknown

A Pilot Study of the Treatment of Facial Nodular and Nodulocystic Basal Cell Carcinoma With Double Curettage and Cautery Followed by Application of Imiquimod to the Base

Basal Cell Carcinoma

United Kingdom
Central Hospital, Nancy, France

Not yet recruiting

Evaluation of Intradermal Hepatitis B Vaccine After IMIQUIMOD's Application, in Cirrhotics Who Did Not Respond to the Usual Vaccine Regimen (IDMODVHB)

Vaccine Reaction | HBV | Cirrhosis, Liver | Vaccination Failure
Centro de Investigaciones Medicas y Ensayos Clinicos...
CALOX Laboratories; Bioanalisis

Unknown

Betaglucin 0.2% Versus Imiquimod 5% in Treatment of Ano-genital Warts: Combined Results From Triple Blind Controlled Study (BETAGENWART)

Genital Wart Virus Infection

Nicaragua
Cedars-Sinai Medical Center

Completed

Dendritic Cell Vaccine With Imiquimod for Patients With Malignant Glioma

Malignant Glioma

United States
Inovio Pharmaceuticals

Completed

Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)

Human Papillomavirus (HPV) | Vulvar Dysplasia | Vulvar Intraepithelial Neoplasia (VIN) | Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) | VIN2 | VIN3 | Pre-cancerous Lesions of the Vulva

United States
University of Miami
Graceway Pharmaceuticals, LLC

Completed

Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal

Healthy

United States
University of California, Irvine
Beckman Laser Institute University of California Irvine

Completed

Combining Topical Imiquimod 5% Cream With a Pulsed Dye Laser to Treat Port Wine Stain Birthmarks (Aldara)

Port Wine Stain

United States
LEO Pharma

Completed

Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%

Actinic Keratosis (AK)

Germany, United Kingdom, France
Rochester General Hospital
Bausch Health Americas, Inc.; Rochester Skin Lymphoma Medical Group, PLLC

Withdrawn

Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma (CTCL)

Mycosis Fungoides
University Medical Centre Maribor

Active, not recruiting

Comparison of Treatment of Cervical Intraepithelial Lesions With Imiquimod or LLETZ

Intraepithelial Neoplasia, Cervical

Slovenia
Barretos Cancer Hospital
Farmoquimica S.A.

Completed

Randomized Clinical Trial Evaluating the Efficacy of Topical Imiquimod in High Grade Cervical Intraepithelial Lesions

Cervix Cancer | High Grade Intraepithelial Neoplasia

Brazil
Maastricht University Medical Center

Active, not recruiting

Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma (SCIN)

Nodular Basal Cell Carcinoma

Netherlands

3

Subscribe